Why in News?

• India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member.

Global AMR R&D:

• The Global AMR R&D Hub was launched in May 2018 in the margins of the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017.
• The Global AMR R&D Hub supports global priority setting and evidence-based decision-making on the allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration and leveraging in AMR R&D.
• The operation of the Global AMR R&D Hub is supported through a Secretariat, established in Berlin and currently financed through grants from the German Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Health (BMG).

Significance of joining Global AMR R&D:

• By partnering with the Global AMR R&D Hub, India looks forward to working with all partners to leverage their existing capabilities, resources and collectively focus on new R&D intervention to address drug-resistant infections
• AMR is the ability of a microbe to resist the effects of medication that once could successfully treat the microbe.
• Today, the emergence and spread of antimicrobial resistance continue unabated around the world.
• Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, India considers it reasonable to explore issues of antimicrobial resistance.